ArriVent BioPharma, Inc. - Common Stock (NQ: AVBP )

19.98 +0.41 (+2.07%)

Streaming Delayed Price Updated: 1:38 PM EDT, May 21, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about ArriVent BioPharma, Inc. - Common Stock

AVBP Stock Earnings: ArriVent BioPharma Beats EPS for Q1 2024

May 08, 2024

AVBP stock results show that ArriVent BioPharma beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

ProfoundBio Discovers The Joys Of Having A Wealthy Owner

April 08, 2024

Key Takeaways: Cancer treatment maker ProfoundBio announced it will be purchased by Denmark’s Genmab for $1.8 billion The deal is the fourth acquisition of a China-related innovative drugmaker by a...

Via Benzinga

Week In Review: AriBio Sells China Rights To Alzheimer’s Candidate In $770 Million Deal

March 30, 2024

South Korea’s AriBio out-licensed China rights for AR1001, an Alzheimer’s disease candidate, in an agreement worth up to $770 million. The company acquiring the asset asked to remain anonymous because...

Via Talk Markets

$10M Bet On ArriVent BioPharma? Check Out These 4 Stocks Insiders Are Buying

February 02, 2024

Although U.S. stocks closed higher on Thursday, there were a few notable insider trades.

Via Benzinga

KKR-Backed BrightSpring Prices Below Expectations, Then Opens Lower

January 28, 2024

Health-care services provider BrightSpring, which is backed by private equity firm KKR, priced its initial public offering at $13, below a marketed range of $15 to $18 per share, before opening on...

Via Talk Markets

Topics Initial Public Offering

Exposures Securities Market

Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China

January 27, 2024

ArriVent BioPharma priced its upsized Nasdaq IPO at $18 dollars per share, raising $175 million. The company’s stated goal is to find promising novel assets from China and other countries, which it...

Via Talk Markets

Topics Initial Public Offering

Exposures Securities Market

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.